Olivier Litzka - 09 Feb 2023 Form 3 Insider Report for Mineralys Therapeutics, Inc. (MLYS)

Role
Director
Signature
/s/ Adam Levy, Attorney-in-fact
Issuer symbol
MLYS
Transactions as of
09 Feb 2023
Net transactions value
$0
Form type
3
Filing time
09 Feb 2023, 18:54:08 UTC
Next filing
01 May 2023

No securities are beneficially owned.

Remarks:

EXHIBIT LIST: EX-24 Litzka Olivier POA